Curis | CRIS - Loan Capital


Curis reported $29.43M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Takeda JPY 4.27T 81.29B Dec/2025
TG Therapeutics USD 245.64M 305K Dec/2025
Verastem USD 50.32M 10.23M Mar/2024
Xoma USD 94.38M 7.82M Sep/2025